UNSPSC 51392408: Dobutamine hydrochloride

This classification denotes an adrenergic agent with the molecular formula C18H23NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0WR771DJXV, chemically known as 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)- but more generally known as dobutamine hydrochloride, which bears US NIH Compound Identifier 36811. European Medicines Agency schedules Dobutamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01803MIG.

UNSPSC 51392408 Dobutamine hydrochloride is a Commodity code that covers pharmaceutical products, though the recent state and local opportunities tagged to this code do not involve dobutamine procurement directly. The two solicitations on record—one from Seminole County, Florida for naloxone and drug deactivation systems, and one from the Texas Health and Human Services Commission for direct-to-manufacturer prescription program capabilities—reflect broader pharmacy and pharmaceutical-access procurement rather than procurement of this specific cardiac medication. State and local health departments and health service commissions are the primary issuing bodies soliciting under pharmaceutical-related codes, including county health departments, state HHS agencies, and specialized community health programs. The work involves both product procurement (naloxone supply for community health initiatives) and vendor capability assessment for pharmaceutical distribution and direct-contracting models.

Geographic activity centers on Florida and Texas, with Seminole County's naloxone IFB posted on June 30, 2026 and due July 26, 2023, and the Texas HHS Commission's RFI for direct-to-manufacturer prescription program vendors posted April 3, 2026. The Seminole County opportunity seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas RFI is an exploratory information-gathering phase seeking vendor experience with direct manufacturer relationships for self-insured employers and state agencies. The code shows limited recent activity specifically for dobutamine hydrochloride, and the opportunities present do not represent active demand for this product line under this Commodity code at this time.